Previous Article | Next Article ![]()
Infection and Immunity, January 2009, p. 387-398, Vol. 77, No. 1
0019-9567/09/$08.00+0 doi:10.1128/IAI.00933-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, One Shields Ave., Davis, California,1 Departamento de Clínica e Cirurgia Veterinárias, Escola de Veterinária, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil2
Received 26 July 2008/ Returned for modification 3 September 2008/ Accepted 9 October 2008
|
|
|---|
), interleukin-22 (IL-22), and IL-17 expression (genes Ifn-
, Il-22, and Il-17, respectively). We investigated here the role of IL-23 in initiating these inflammatory responses using the streptomycin-pretreated mouse model. Compared to wild-type mice, the expression of IL-17 was abrogated, IL-22 expression was markedly reduced, but IFN-
expression was normal in the ceca of IL-23p19-deficient mice during serotype Typhimurium infection. IL-23p19-deficient mice also exhibited a markedly reduced expression of regenerating islet-derived 3 gamma, keratinocyte-derived cytokine, and reduced neutrophil recruitment into the cecal mucosa during infection. Analysis of CD3+ lymphocytes in the intestinal mucosa by flow cytometry revealed that
β T cells were the predominant cell type expressing the IL-23 receptor in naive mice. However, a marked increase in the number of IL-23 receptor-expressing 
T cells was observed in the lamina propria during serotype Typhimurium infection. Compared to wild-type mice, 
T-cell-receptor-deficient mice exhibited blunted expression of IL-17 during serotype Typhimurium infection, while IFN-
expression was normal. These data suggested that 
T cells are a significant source, but not the sole source, of IL-17 in the acutely inflamed cecal mucosa of mice. Collectively, our results point to IL-23 as an important player in initiating a T-cell-dependent amplification of inflammatory responses in the intestinal mucosa during serotype Typhimurium infection. |
|
|---|
[Ifn-
gene]), interleukin-17 (IL-17 [Il-17 gene]), and IL-22 (Il-22 gene) (9, 24, 25). T cells play an important role in amplifying inflammatory responses in the cecal mucosa, because depletion of CD3+ cells causes in a dramatic reduction in cecal inflammation and neutrophil recruitment (9). T-cell depletion also results in a markedly blunted induction of Ifn-
, Il-17, and Il-22 in the intestinal mucosa during serotype Typhimurium infection (9, 25). IL-17 and IL-22 help to orchestrate intestinal inflammation by inducing the production of neutrophil chemoattractants (e.g., keratinocyte-derived cytokine [KC] or IL-8), dendritic cell chemoattractants (e.g., CCL20), and antimicrobials (e.g., Lipocalin-2 and iNOS) in the mucosa (9, 25, 42). However, the mechanisms by which T-cell-dependent amplification of responses to serotype Typhimurium infection is initiated in the intestinal mucosa have not been explored experimentally.
In other models of infection, cytokines released by macrophages or dendritic cells have been implicated in stimulating cytokine production by T cells. For example, detection of bacterial flagellin by cytosolic pattern recognition receptors in macrophages activates caspase 1, resulting in the release of mature IL-18 (6, 20, 21, 34). IL-18 can stimulate antigen experienced T cells to rapidly secrete IFN-
during bacterial infection by an antigen-independent mechanism, thereby significantly amplifying early effector responses in vivo (32). In a mouse model of Klebsiella pneumoniae lung infection, bacterial stimulation of Toll-like receptor 4 (TLR4) on dendritic cells results in IL-23 production (13). IL-23 in turn triggers the rapid production of IL-17 and IL-22 by T cells (1, 12), which is required for efficient neutrophil recruitment in this model (39, 40). IL-23 has also been implicated in enhancing inflammatory responses elicited by other bacterial pathogens, including Citrobacter rodentium, Pseudomonas aeruginosa, Mycoplasma pneumoniae, and Mycobacterium bovis (5, 36, 38, 42). The goal of the present study was to determine whether IL-23 contributes to an amplification of inflammatory responses in the cecal mucosa during serotype Typhimurium infection of streptomycin-pretreated mice.
|
|
|---|
Animal experiments.
Mice deficient in p19 (IL-23p19–/– mice) were generated by breeding B6.129S5-Il23p19tm1Lex mice with C57BL/6 mice under specific-pathogen-free conditions in a barrier facility. IL-23p19–/– mice and wild-type littermates were bred and genotyped at the Mutant Mouse Regional Resource Center at the University of California, Davis. Mice deficient for Tcd, the gene encoding the
T-cell receptor chain, were obtained from the Jackson Laboratory (B6.129P2-Tcrdtm1Mom/J).
To study inflammation in the cecum, streptomycin-pretreated mice were orally infected with serotype Typhimurium as described previously (2). In brief, mice were inoculated with streptomycin (0.1 ml of a 200-mg/ml solution in sterile water) intragastrically. IL-23p19–/– mice (n = 16) and wild-type littermates (n = 9) were inoculated intragastrically 24 h later with bacteria (0.1 ml containing approximately 5 x 108 CFU). As a control, IL-23 p19–/– mice (n = 6) and wild-type littermates (n = 8) were inoculated with 0.1 ml of sterile LB broth (mock infection). Trd–/– (n = 6) and wild-type C57/B6 (n = 5) mice were infected as described above with serotype Typhimurium. As a control, wild-type (n = 6) and Trd–/– mice (n = 4) were inoculated with 0.1 ml of LB broth (mock infection). At 48 h after infection, mice were euthanized, and samples of the cecum collected for isolation of mRNA and for histopathological analysis. For bacteriologic analysis, cecal contents and Peyer's patches were homogenized, and serial 10-fold dilutions were spread on agar plates containing the appropriate antibiotics. For isolation of intraepithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL) from infected mice, three groups of two 8- to 10-week-old mice (C57BL/6; Jackson Laboratory) were inoculated with streptomycin (0.1 ml of a 200-mg/ml solution in sterile water) intragastrically. After 24 h, the mice were inoculated with bacteria (0.1 ml containing approximately 5 x 108 CFU). IEL and LPL were isolated 48 h postinfection.
Real-time PCR. For analysis of the changes in gene expression after serotype Typhimurium infection in the mouse cecum, tissue samples were collected and immediately snap-frozen in liquid nitrogen at the site of surgery and stored at –80oC until processing. RNA was then extracted from snap-frozen tissue with TriReagent (Molecular Research Center) according to the instructions of the manufacturer. Next, 1 µg from each sample was reverse transcribed in 50 µl of TaqMan reverse transcription reagent (Applied Biosystems), and 4 µl of cDNA was used for each real-time reaction. Real-time PCR was performed using Sybr green (Applied Biosystems) and the 7900HT fast real-time PCR system. The data were analyzed by using a comparative threshold cycle method (Applied Biosystems). Increases in cytokine expression in infected mice were calculated relative to the average level of the respective cytokine in eight mock-infected wild-type mice. A list of genes analyzed in the present study with the respective primers is provided in Table 1.
|
View this table: [in a new window] |
TABLE 1. Primers for real-time PCR
|
Histopathology. Tissue samples were fixed in formalin, processed according to standard procedures for paraffin embedding, sectioned at 5 µm, and stained with hematoxylin and eosin. A veterinary pathologist scored inflammatory changes using a blind-sample analysis. Neutrophil counts were determined per high (x400)-magnification microscopy, and numbers were averaged from 10 microscopic fields for each animal.
Isolation of intestinal lymphocytes.
IEL and LPL were isolated from C57BL/6 mice by standard procedures (4, 19, 30). Briefly, three groups of two naive mice and three groups of two serotype Typhimurium-infected mice were euthanized, and organs from each group of mice were combined. Intestines were removed beginning from the duodenum and ending at the proximal colon. Intestines were dissected by removing the remaining mesentery and vasculature. Each segment was then opened longitudinally, the luminal content was removed, and the tissue was cut into
5-mm sections with a scalpel. The sections were subsequently washed in cold 1x Hanks balanced salt solution (HBSS; Gibco catalog no. 14185) containing 0.015 M HEPES (Gibco catalog no.15630) a total of six times to remove mucus and remaining fecal matter.
For IEL isolation, tissue was placed and stirred for 15 min at room temperature in prewarmed (37°C) 1x HBSS containing 10% fetal bovine serum (Gibco catalog no. 10082), 0.015 M HEPES, and 5 mM EDTA and stirred for 15 min 37°C, followed by three 15-min washes with buffer adjusted to room temperature. The supernatant from each wash was pooled and poured through a nylon wool column to enrich for T cells and remove mucus. The resulting cell suspension was used to analyze IEL.
To isolate LPL, the tissue remaining after IEL isolation was stirred in prewarmed (37°C) 1x RPMI (Sigma catalog no. R1145) containing 10% fetal bovine serum, penicillin-streptomycin (Gibco catalog no.15240-062), 0.015 M HEPES, and 1.6 mg of collagenase (Sigma-Aldrich catalog no. C6885)/ml for 45 min in a 37°C incubator. The resulting cell suspension was washed twice with 1x HBSS containing 0.015 M HEPES, enriched for T cells using a nylon wool column, and used to analyze LPL.
Flow cytometry. The IEL and LPL suspensions containing approximately 4 x 106 cells each were resuspended in cold phosphate-buffered saline and stained with Aqua Live/Dead cell discriminator (Invitrogen catalog no. L34597) according to the manufacturer's protocol. Cells were then stained for 1 h in the dark at 4°C with optimized concentrations of anti-CD3 Alexa750-APC (eBioscience clone 17A2), anti-CD8 Alexa700 (eBioscience clone 53-6.7), anti-CD4 Pacific Blue (eBioscience clone RM4-5), anti-TCR GD R-PE (BD Pharmingen clone GL3), and biotinylated polyclonal anti-IL-23R (BAF1686; R&D Systems). Cells were washed twice with PBS containing 1% bovine serum albumin (fluorescence-activated cell sorting [FACS] buffer). Cells were then stained for 1 h with streptavidin-conjugated Qdot 605 (Q10101MP; Invitrogen). Stained cells were washed once in FACS buffer and subsequently fixed in 4% formalin for 1 h. Cells were then washed once and resuspended in FACS buffer and analyzed using an LSR II flow cytometer (Becton Dickinson, San Jose, CA). The data were analyzed by using FlowJo software (Treestar, Inc., Ashland, OR). Gates were set on singlets and then on live lymphocytes. Subsequent gates were based on Fluorescence-Minus-One and unstained controls.
Statistical analysis. Fold changes in mRNA levels measured by real-time PCR underwent logarithmic transformation, and percentage values underwent angular transformation prior to analysis by Student t test.
|
|
|---|
expression in the cecal mucosa during serotype Typhimurium infection.
We have recently shown that Ifn-
, Il-17, and Il-22 are among the genes whose transcript levels are increased most prominently in the ceca of streptomycin-pretreated mice during serotype Typhimurium infection (9). To study the contribution of IL-23 in triggering cytokine production in the cecal mucosa, we compared the mRNA levels of Ifn-
, Il-17, and Il-22 in IL-23-deficient mice and their wild-type littermates in response to inoculation with serotype Typhimurium or sterile LB broth (mock infection). IL-23 is a heterodimer composed of p19 and p40. The p40 subunit is shared with IL-12, a heterodimer of p40 and p35. We used IL-23p19–/– mice to determine the role of IL-23 in amplifying inflammatory responses in the intestine. We recently established the time course of cytokine production in the streptomycin-pretreated mouse model, which shows that proinflammatory cytokines are strongly induced in the cecal mucosa by 48 h after serotype Typhimurium infection (9). We therefore chose the 48-h time point for experiments described in the present study.
We compared mRNA levels of cytokines to levels detected in mock-infected wild-type mice (Fig. 1). As expected, Il-23p19 mRNA was not detected in either mock-infected or serotype Typhimurium-infected IL-23p19–/– mice (Fig. 1A). Compared to mock-infected wild-type mice, Il-23p19 mRNA levels were increased
10-fold in wild-type mice infected with serotype Typhimurium. Importantly, while Il-17 mRNA levels were markedly increased in serotype Typhimurium-infected wild-type mice, no induction of Il-17 expression was observed in IL-23p19–/– mice (Fig. 1B). These data suggested that the induction of Il-17 expression in the cecal mucosa of mice 48 h after serotype Typhimurium infection was fully dependent on the presence of IL-23. While Il-22 mRNA levels were increased in response to serotype Typhimurium infection in both wild-type and IL-23p19–/– mice, induction was significantly greater (P < 0.001) in wild-type mice (Fig. 1C). These data suggested that IL-23-dependent mechanisms contributed to an induction of Il-22 expression in the cecal mucosa of mice. However, the increase in Il-22 mRNA levels observed in serotype Typhimurium-infected IL-23p19–/– mice suggested that IL-23-independent mechanisms also contributed to IL-22 production in vivo. Serotype Typhimurium infection induced Ifn-
mRNA to similar levels in both wild-type mice and IL-23p19–/– mice (Fig. 1D), indicating that IFN-
production is induced by IL-23-independent mechanisms in the cecal mucosa. The lower degree of Il-17 and Il-22 expression in the ceca in IL-23p19–/– mice was not due to differences in bacterial load because similar bacterial numbers were recovered from intestinal contents and the intestinal tissue of serotype Typhimurium-infected wild-type mice and IL-23p19–/– mice (Fig. 1E).
![]() View larger version (23K): [in a new window] |
FIG. 1. Cytokine expression elicited by serotype Typhimurium in streptomycin pretreated wild-type mice ( ) and streptomycin-pretreated IL-23-deficient mice ( (D) compared to mRNA levels detected in a group of mock-infected wild-type mice (n = 8). The data are shown as geometric means of fold changes ± the standard error determined for RNA from individual mice. (E) Average bacterial numbers (in CFU) recovered 48 h after serotype Typhimurium infection from colon contents or Peyer's patch tissues of wild-type mice ( ) or IL-23-deficient mice (
|
![]() View larger version (14K): [in a new window] |
FIG. 2. Absolute transcript levels of Il-17 (A) and Reg3g (B) in IL-23p19-deficient mice (IL-23p19–/–, ) determined by quantitative real-time PCR 48 h after mock infection or infection with serotype Typhimurium. The data represent mean mRNA copy numbers per 20 ng of RNA ± the standard error. Statistically significant differences are indicated by P values.
|
200-fold) in serotype Typhimurium-infected wild-type mice (Fig. 3A). The induction of Kc expression was notably blunted in the ceca of serotype Typhimurium-infected IL-23p19–/–mice compared to serotype Typhimurium-infected wild-type mice (P < 0.001). These data suggested that IL-23 is required for the full induction of neutrophil chemoattractants in the cecal mucosa during serotype Typhimurium infection.
![]() View larger version (51K): [in a new window] |
FIG. 3. Neutrophil recruitment into the cecal mucosa. (A) Expression of the neutrophil chemoattractant Kc gene elicited by serotype Typhimurium in streptomycin-pretreated wild-type mice ( ) and streptomycin-pretreated IL-23-deficient mice (
|
The IL-23 receptor is expressed by a subset of intestinal T cells.
We have recently shown that depletion of T cells results in a marked reduction in the expression levels of Il-17 and Il-22 in the ceca of streptomycin-pretreated mice during serotype Typhimurium infection (9). These data suggest that the IL-17/IL-22 deficiency observed in IL-23p19–/– mice (Fig. 1) could be explained by hypothesizing that IL-23 stimulates a subset of intestinal T cells to produce IL-17 and IL-22. This hypothesis would predict that a subset of intestinal T cells expresses the receptor for IL-23. To test this prediction, we isolated IEL (Fig. 4A) and LPL (Fig. 4B) from the intestines of mice and analyzed expression of surface markers by flow cytometry. Intraepithelial CD3+ cells were divided into cells expressing the 
T-cell receptor (
T cells) and 
T-cell-receptor-negative cells (
β T cells) (Fig. 4C). Finally,
β T-cell subsets were defined based on expression of CD4 and CD8 (Fig. 4D). The same procedure was applied to lamina propria CD3+ cells (Fig. 4E and F).
![]() View larger version (37K): [in a new window] |
FIG. 4. Isolation of T cells from the intestinal epithelium and lamina propria. The total numbers of live CD3+ cells present in preparations of IEL (A) and LPL (B) from naive mice (n = 6, ) were determined. (C) Representative example of the gating strategy used to define ![]() + and ![]() – T-cell populations among live IEL. (D) Representative example of the gating strategy used to separate intraepithelial ![]() – T cells into different subsets. (E) Representative example of the gating strategy used to define ![]() + and ![]() – T-cell populations among live LPL. (F) Representative example of the gating strategy used to separate lamina propria ![]() – T cells into different subsets. In panels C to F, the axis represents the fluorescence intensity produced by fluorescent antibody conjugates recognizing the ![]() T-cell receptor (![]() TCR), CD3, CD4, or CD8.
|

T-cell receptor in naive mice (i.e., CD8+ 
+ T cells and CD8– 
+ T cells constituted ca. 40% of intraepithelial CD3+ T cells) (Fig. 5A). In contrast, 
T cells were only a minor population (ca. 10%) of the lamina propria CD3+ cell population, which was dominated by CD4+ T cells. That is, ca. 50% of CD3+ cells in the lamina propria were CD4+ CD8– 
– T cells (Fig. 5B). These data were consistent with previous studies on the composition of intestinal intraepithelial and lamina propria CD3+ cell populations in the mouse (8). No significant differences in the relative proportions of T-cell subsets were observed during analysis of tissue collected from naive mice compared to tissue collected from serotype Typhimurium-infected mice (Fig. 5).
![]() View larger version (22K): [in a new window] |
FIG. 5. Characterization of T-cell subsets in the intestines of naive mice (n = 6, ). (A) T-cell subsets in the IEL population are shown as a percentage of the total number of intraepithelial T cells (CD3+ IEL). (B) T-cell subsets in the LPL population are shown as a percentage of the total number of lamina propria T cells (CD3+ LPL). The data are shown as means ± the standard error.
|

– cells, regardless of whether tissue had been collected from naive mice or from serotype Typhimurium-infected mice (Fig. 6A). Previous studies suggest that CD4– CD8– 
– cells in the gut mucosa of mice comprise natural killer T (NKT) cells and CD4– CD8– T cells (15). In the CD3+ LPL population of naive mice, the majority of cells expressing the IL-23 receptor were either CD4– CD8– 
– cells or CD4+ CD8– 
– cells (potentially representing TH17 cells) (Fig. 6B).
![]() View larger version (26K): [in a new window] |
FIG. 6. Expression of IL-23 receptor by intraepithelial T cells (A) and lamina propria T cells (B) in the intestines of naive mice (n = 6, ). (A) IL-23 receptor-expressing cells expressing the indicated markers (CD4, CD8, and/or ![]() T-cell receptor [TCR]) are shown as a percentage of the total number of intraepithelial T cells (CD3+ IEL). (B) IL-23 receptor-expressing cells expressing the indicated markers (CD4, CD8 and/or ![]() TCR) are shown as a percentage of the total number of lamina propria T cells (CD3+ LPL). The data are shown as means ± the standard error. Statistical significance of differences is indicated by P values. (C) Representative example of IL-23 receptor expression by CD8– ![]() + lamina propria T cells pooled from the intestine of two naive mice (left panel) or two serotype Typhimurium-infected mice (right panel). IL-23R, IL-23 receptor.
|

+ cells expressing the IL-23 receptor (Fig. 6C). This notable increase in IL-23 receptor-expressing 
T cells during serotype Typhimurium infection raised the overall fraction of CD3+ LPL that expressed the receptor for IL-23 above 20%. In summary, our results show that a fraction (10 to 20%) of CD3+ lymphocytes in the intestinal mucosa of mice express the receptor for IL-23. Furthermore, 48 h after serotype Typhimurium infection, we observed a marked increase in IL-23 receptor-expressing 
T cells.

T cells contribute to Il-17 expression in the inflamed cecal mucosa of mice.
Since an increase in IL-23 receptor expressing 
T cells was the only notable change in mucosal T-cell populations observed during serotype Typhimurium infection (Fig. 6B and C), we investigated whether 
T cells contribute to cytokine production in the inflamed murine cecum. To this end, we compared the mRNA levels of Ifn-
and Il-17 in 
T-cell-receptor-deficient (Trd–/–) mice and wild-type controls (C57BL/6 mice) in response to inoculation with serotype Typhimurium or sterile LB broth (mock infection) (Fig. 7). There was a compensatory increase in Il-23p19 mRNA expression in serotype Typhimurium-infected 
T-cell-receptor-deficient mice (Fig. 7A). Il-17 mRNA levels induced during serotype Typhimurium infection were significantly lower in 
T-cell-receptor-deficient mice than in the wild type (P < 0.05) (Fig. 7B). In contrast, serotype Typhimurium infection induced Ifn-
mRNA (Fig. 7C) and Il-22 mRNA (Fig. 7D) to similar levels in both wild-type mice and 
T-cell-receptor-deficient mice. Similar bacterial numbers were recovered from the intestinal contents of infected mice (Fig. 7E). These data suggested that 
T cells contributed to Il-17 expression in the inflamed cecal mucosa. However, unlike IL-23p19–/– mice, 
T-cell-receptor-deficient mice still exhibited increased Il-17 mRNA levels in response to serotype Typhimurium infection, suggesting that 
T cells are not the sole source of IL-17 in the inflamed cecum.
![]() View larger version (24K): [in a new window] |
FIG. 7. Cytokine expression elicited by serotype Typhimurium in streptomycin-pretreated wild-type mice (C57BL/6, ) or streptomycin-pretreated T-cell-receptor -chain-deficient mice (Trd–/–, (C), and Il-22 (D) compared to mRNA levels detected in a group of mock-infected wild-type mice (n = 8). The data are shown as geometric means of fold changes ± the standard error determined for RNA from individual mice. (E) Average bacterial numbers (in CFU) recovered 48 h after serotype Typhimurium infection from the colon contents or Peyer's patch tissues of wild-type mice ( ) or ![]() T-cell-receptor-deficient mice (
|

T-cell deficiency induced Il-17 expression in response to serovar Typhimurium infection (P = 0.003), but transcript levels were markedly reduced compared to those measured in wild-type mice infected with serotype Typhimurium (P = 0.03) (Fig. 8A). These data further supported the idea that 
T cells contribute Il-17 expression in the cecal mucosa. Although the absolute transcript levels of Reg3g were reduced (Fig. 8B) and lower numbers of neutrophils were observed in cecal tissue of 
T-cell-receptor-deficient mice during serotype Typhimurium infection (Fig. 8C), these differences were not statistically significant. Our data suggest that the partial inhibition of Il-17 expression (Fig. 7B and 8A), which was accompanied by normal expression of Il-22 (Fig. 7D), was not sufficient to significantly reduce Reg3g expression or neutrophil recruitment in 
T-cell-receptor-deficient mice (Fig. 8B and C). Thus, while 
T cells contribute to Il-17 expression, our data suggest that there must be additional cellular sources to fully account for the increased IL-17 and IL-22 production in the inflamed cecum of the mouse.
![]() View larger version (18K): [in a new window] |
FIG. 8. Absolute transcript levels of Il-17 (A) and Reg3g (B) in ![]() T-cell-receptor-deficient mice (Trd–/–, ) determined by quantitative real-time PCR 48 h after mock infection or infection with serotype Typhimurium. The data represent mean mRNA copy numbers per 20 ng of RNA ± the standard error. (C) Numbers of neutrophils per microscopic field were determined by a veterinary pathologist during a blinded examination of slides from the cecal mucosa. The data represent means ± the standard error. Statistically significant differences are indicated by P values above brackets. NS, not significant.
|
|
|
|---|
, IL-22, and IL-17, which are among the most prominently induced cytokines in serotype Typhimurium-infected tissue (9). These data suggest that T cells are an important component of mechanisms that help to amplify inflammatory responses to serotype Typhimurium infection in the intestinal mucosa. However, little is known about how serotype Typhimurium infection initiates these T- cell-dependent amplification mechanisms. We show here that diverse subsets of T cells in the intestinal mucosa express the receptor for IL-23, a cytokine important for initiating the production of KC, REG3
, IL-22, and IL-17 in response to serotype Typhimurium infection. IFN-
production was not affected by IL-23 deficiency, suggesting that the early expression of this important cytokine by T cells (i.e., at 2 days after infection) is triggered through other pathways, perhaps involving IL-12 or IL-18 production. For example, IL-18 has recently been implicated in amplifying inflammatory responses early after serotype Typhimurium infection in the spleens of mice by triggering IFN-
production in antigen experienced CD4 T cells by an antigen-independent mechanism (32).
Two important questions arise from the results of our study. First, which intestinal T-cell subsets contribute to IL-17 and IL-22 production during serotype Typhimurium infection? In the lung mucosa, 
T cells have been implicated as an important source of IL-17 during Mycobacterium tuberculosis and M. bovis infection (18, 22, 36). Similarly, injection of Escherichia coli into the peritoneal cavity of naive mice triggers IL-23 production in a TLR4 signaling-dependent manner, and the resulting IL-17 production originates largely from 
T cells (28). Our results suggest that 
T cells are also one of the cellular sources of IL-17 in the serotype Typhimurium-infected mouse. However, 
T-cell-deficient mice were still able to produce Il-17 mRNA, albeit at reduced levels, during serotype Typhimurium infection, suggesting that additional cell types contributed to production of this cytokine in the inflamed cecum. In addition to 
T cells, the receptor for IL-23 was expressed predominantly by CD3+ CD4– CD8– 
– cells (NKT cells and/or CD4– CD8– T cells) in the intestinal epithelium and by CD4+ T cells and CD3+ CD4– CD8– 
– cells in the lamina propria. Each of these cell types has been implicated as a source of IL-17 production in different animal models of inflammation (3, 13, 16, 17, 23, 25). A distinct subset of CD4– NKT cells produces IL-17, contributing to infiltration of neutrophils in a galactosylceramide-induced model of airway inflammation (17). NKT cells constitutively express IL-23 receptor and rapidly produce IL-17 upon stimulation with IL-23 (23). IL-17 mRNA has been shown to be specifically expressed by a subset of murine CD4– CD8– T cells (16). In contrast, IL-17 is mainly derived from CD4+ T cells during M. pneumoniae lung infection (38). Both CD4+ T cells and CD8+ T cells are a source of IL-17 during infection of mice with Helicobacter pylori (3) or K. pneumoniae (13). Finally, depletion of memory CD4+ T cells by simian immunodeficiency virus blunts IL-17 responses elicited early (i.e., 5 h) after serotype Typhimurium infection of the ileal mucosa in rhesus macaques (25), pointing to an innate induction of these T-cell responses. Thus, TH17 cells contribute to IL-17 production in the ileal mucosa of a relevant animal species.
The second question arising from the present study relates to the mechanisms that initiate IL-23 production during serotype Typhimurium infection. Electron microscopic analysis of serotype Typhimurium infection shows that all bacteria detected in the intestinal mucosa have an intracellular location, either within mononuclear phagocytes (macrophages and/or dendritic cells) or within neutrophils (7, 26). Since only a very small fraction of cells in infected tissue contain bacteria, the total capacity for cytokine production by these cells may be limited in scope. However, macrophages and dendritic cells infected with serotype Typhimurium are a potential source of IL-23, and our data suggest that this cytokine helps to amplify a subset of inflammatory responses in tissue. During K. pneumoniae infection, release of IL-23 by dendritic cells in the lung mucosa is triggered through stimulation of TLR4 by lipopolysaccharide (13). Similarly, production of IL-23 by murine bone marrow-derived dendritic cells in response to S. enterica serotype Enteritidis infection is TLR4 dependent (29). However, CD11c+ CX3CR1+ mucosal dendritic cells do not generate MyD88-dependent responses in the ceca of serotype Typhimurium-infected mice (10), suggesting that the signals produced at mucosal sites are not mimicked adequately by bone marrow-derived cells. A recent finding that points to macrophages as possible sources of IL-23 is the observation that the inflamed human intestine contains a unique subset of CD14+ intestinal macrophages, which produces larger amounts of IL-23 than the resident CD14– macrophages (14). Alternatively, serotype Typhimurium may stimulate mucosal dendritic cells or mucosal macrophages to produce IL-23 through MyD88-independent mechanisms, which have been proposed to contribute to cecal inflammation (11). One possible MyD88-independent mechanism leading to IL-23 production by dendritic cells is the activation of the intracellular bacterial sensor NOD2. IL-23 produced by this NOD2-dependent, MyD88-independent mechanism results in IL-17 production in human memory T cells (37). However, additional work is needed to understand the precise mechanisms by which the IL-23/IL-17 axis is triggered in the intestinal mucosa during serotype Typhimurium infection.
This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR12088-01 from the National Center for Research Resources, National Institutes of Health. Work in A.J.B.'s laboratory was supported by Public Health Service grants AI040124, AI044170, and AI079173. T.A.P. and R.L.S. are recipients of fellowships from the Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brasília, Brazil. I.G. was supported by Public Health Service grant AI060555.
Published ahead of print on 27 October 2008. ![]()
|
|
|---|
β TCR+ CD4– CD8– T cells. J. Interferon Cytokine Res. 16:611-617.[Medline]
T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177:4662-4669.
T cells increased in patients with active pulmonary tuberculosis. Cell Mol. Immunol. 5:203-208.[Medline]
1+ 
T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178:4466-4472.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»